Jun 04, 2012 9:00am EDT Immunovaccine's DPX-0907 Demonstrates Ability to Generate Promising Immune Reponses in Multiple Cancers in a Clinical Trial Presented at ASCO Annual Meeting
May 29, 2012 8:30am EDT Immunovaccine to Present Clinical Data on its DPX-0907 Cancer Vaccine at the 2012 ASCO Annual Meeting
May 24, 2012 4:05pm EDT Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012
May 10, 2012 8:05am EDT Immunovaccine Signs Collaboration to Develop Sustained-Acting, Single Dose Vaccines for Pets
Apr 13, 2012 9:07am EDT Immunovaccine Inc. Named "Best Early-Stage Vaccine Biotech" at the 5th Vaccine Industry Excellence (ViE) Awards